About Us
Research Watch
The Heavy Burden of Bullying on Student Wellbeing in NepalThe Emerging Landscape of Thyroid Health in Central NepalHow a Recent Western Nepal Study is Redefining Anemia DiagnosisHow H. Pylori is Impacting the Health of Karnali’s High-Altitude CommunitiesSweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s YouthHow Missing Checklists and Protocols are Costing Lives in Nepal’s ERsWhy Your Lungs May Hold the Secret to Your Stress LevelsWalking in Fear: Why Nepal’s Streets Aren't Safe and the Race to Stop a "Hidden Killer"Why Poor Living and Working Conditions are Shattering the Mental Health of Nepali WorkersSilent Suffering: Why Nepal’s Doctors and Nurses Are Not Reporting Child AbuseThe Heavy Burden of Bullying on Student Wellbeing in NepalThe Emerging Landscape of Thyroid Health in Central NepalHow a Recent Western Nepal Study is Redefining Anemia DiagnosisHow H. Pylori is Impacting the Health of Karnali’s High-Altitude CommunitiesSweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s YouthHow Missing Checklists and Protocols are Costing Lives in Nepal’s ERsWhy Your Lungs May Hold the Secret to Your Stress LevelsWalking in Fear: Why Nepal’s Streets Aren't Safe and the Race to Stop a "Hidden Killer"Why Poor Living and Working Conditions are Shattering the Mental Health of Nepali WorkersSilent Suffering: Why Nepal’s Doctors and Nurses Are Not Reporting Child Abuse

NCCN Guidelines® Insights: Acute Myeloid Leukemia, Version 3.2026.

Researchers

Daniel A Pollyea, Jessica K Altman, Rita Assi, Kimo Bachiashvili, Vijaya Raj Bhatt, Amir T Fathi, Kateryna Fedorov, James M Foran, Ivana Gojo, Aaron Goldberg, Aric C Hall, Brian A Jonas, Matthew R Levine, James Mangan, Gabriel Mannis, Guido Marcucci, Alice Mims, Kelsey Moriarty, Moaath Mustafa Ali, Jadee Neff, Reza Nejati, Rebecca Olin, Anand Patel, Mary-Elizabeth Percival, Alexander Perl, Kristen Pettit, Dinesh Rao, Farhad Ravandi, Zaker Schwabkey, Rory Shallis, Maximilian Stahl, Richard M Stone, Swapna Thota, Geoffrey L Uy, Alison Walker, Eunice Wang, Ajibola Awotiwon, Sydney L Roth, Katie Stehman

Abstract

Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized by the clonal expansion of myeloid blasts in the peripheral blood, bone marrow, and/or other tissues. It is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths from leukemias in the United States.1 The NCCN Guidelines Panel for AML convenes annually to update recommendations for the diagnosis and treatment of AML in adults. These recommendations are based on a review of recently published clinical trials that have led to significant improvements in treatment or have yielded new information regarding biologic factors that may have prognostic importance. These NCCN Guidelines Insights summarize the panel's most recent recommendations regarding the monitoring and management of measurable (minimal) residual disease.
Source: PubMed (PMID: 42297017)View Original on PubMed